Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $58.13 +4.16%
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.74, $0.09 better than the analyst estimate of $0.65. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.19 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2016 EPS of $2.50-$2.60, versus the consensus of $2.40.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- Freedom Broker Starts Unity Bancorp (UNTY) at Hold
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
